会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明授权
    • Controlled release formulation
    • 控释制剂
    • US4756911A
    • 1988-07-12
    • US852681
    • 1986-04-16
    • Joseph D. DrostGeorge E. ReierNemichand B. Jain
    • Joseph D. DrostGeorge E. ReierNemichand B. Jain
    • A61K9/20A61K9/22A61K9/28
    • A61K9/2866A61K9/2054
    • A controlled release pharmaceutical formulation which undergoes substantially or approaches zero order release of active drug is provided, preferably in the form of a coated tablet, containing a core portion from which medicament, such as procainamide hydrochloride, is slowly released over a controlled length of time. The core also includes one or more primary hydrocolloid gelling agents which is a hydropropylmethyl cellulose having a viscosity of within the range of from about 1,000 to about 6,000 centipoises in 2% solution at 20.degree. C., and a methoxyl content of 28-30%, optionally a secondary hydrocarbon gelling agent, such as hydroxypropyl cellulose and/or methyl cellulose, one or more non-swellable binders and/or wax binders (where the medicament and/or hydrocolloid gelling agents are non-compressible), one or more inert fillers or excipients, one or more lubricants, and optionally one or more anti-adherents such as silicon dioxide and water. The above-described core is coated with a pharmaceutical coating composition containing a hydrophobic polymer and a hydrophilic polymer.
    • 提供基本上或接近零级释放活性药物的控释药物制剂,优选为包衣芯片形式的包衣片剂形式,其中药物如盐酸普鲁卡因酰胺在受控的时间内缓慢释放 。 核心还包括一种或多种主要的水胶体胶凝剂,其是在20℃在2%溶液中具有约1,000至约6,000厘泊的粘度的羟丙基甲基纤维素,以及甲氧基含量为28-30% ,任选的第二烃胶凝剂,例如羟丙基纤维素和/或甲基纤维素,一种或多种不溶胀粘合剂和/或蜡粘合剂(其中药物和/或水胶体胶凝剂是不可压缩的),一种或多种惰性 填充剂或赋形剂,一种或多种润滑剂,以及任选的一种或多种抗粘附剂,例如二氧化硅和水。 上述核心涂覆有含有疏水性聚合物和亲水性聚合物的药物涂料组合物。